Rare Diseases: Meeting the Unique Challenges of Orphan Drug Development

Emphasizing the importance of the patient to overcome orphan drug development challenges

Read more

While individually rare, orphan diseases are collectively common, with an estimated 350 million sufferers worldwide. Read about the unique challenges that are present in orphan drug development and how to overcome them.


Chief Medical and Scientific Officer

Want to learn more about Worldwide Clinical Trials?